Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

TBT - The Top 5 Papers of 2024

25:23
 
Share
 

Manage episode 497515923 series 3381372
Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Welcome back Rounds Table Listeners! In this throwback episode, Drs. Mike and John Fralick chat about five important research studies published in 2024:

  1. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF) (0:00 – 4:09)
  2. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) (4:10 – 9:28)
  3. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) (9:29 – 14:23)
  4. Tirzepatide for Metabolic-Dysfunction Associated Steatohepatitis with Liver Fibrosis (SYNERGY-NASH) (14:24 – 20:28)
  5. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BALANCE) (20:29 – 23:59)

And for the Good Stuff:

Calling keen trainees!

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

  continue reading

389 episodes

Artwork
iconShare
 
Manage episode 497515923 series 3381372
Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Welcome back Rounds Table Listeners! In this throwback episode, Drs. Mike and John Fralick chat about five important research studies published in 2024:

  1. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF) (0:00 – 4:09)
  2. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) (4:10 – 9:28)
  3. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) (9:29 – 14:23)
  4. Tirzepatide for Metabolic-Dysfunction Associated Steatohepatitis with Liver Fibrosis (SYNERGY-NASH) (14:24 – 20:28)
  5. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BALANCE) (20:29 – 23:59)

And for the Good Stuff:

Calling keen trainees!

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

  continue reading

389 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play